Neuroimaging as endpoints in clinical trials: Are we there yet? Perspective from the first Provence workshop

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular psychiatry 2011-11, Vol.16 (11), p.1064-1066
Hauptverfasser:	Valenzuela, M, Bartrés-Faz, D, Beg, F, Fornito, A, Merlo-Pich, E, Müller, U, Öngür, D, Toga, A W, Yücel, M
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308/2779/109 692/700/1421/65 Alzheimer's disease Behavioral Sciences Biological Psychology Brain - drug effects Brain - pathology Central Nervous System Agents - pharmacology Central Nervous System Agents - therapeutic use Clinical trials Clinical Trials as Topic - methods Conferences, meetings and seminars Drug Discovery Endpoint Determination Genomes Humans Magnetic resonance imaging Medical imaging Medicine Medicine & Public Health Neuroimaging Neurosciences news-and-commentary Organ Size Patients Pharmacotherapy Physiology Power Precision Medicine Psychiatry Spectrum analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!